Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1809097
Name of medicinal product: Mirataz
Active substances:
Mirtazapine
Estonian, English, Latin
ATC code: QN06AX11
Dosage form: transdermal ointment
Route of administration: transdermal use
Strengh: 20mg 1g
Amount in package: 5g 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions (see section 5.1).
Safety features: No
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Withdrawal time:  
Species: kass
Last imported to Estonia: June 14, 2022
Marketing authorization holder: Dechra Regulatory B.V. 
Marketing authorization number: EU/2/19/247 
Marketing authorization issued on: December 10, 2019 
Marketing authorization expires on: December 12, 2024 
Marketing authorization procedure type: Centralised 
Entry/Changing date: July 9, 2020
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere